Get the Stockscreener App
19.08
2.60%
-0.51
Pulse Biosciences Inc stock is traded at $19.08, with a volume of 201.69K.
It is down -2.60% in the last 24 hours and up +0.10% over the past month.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
See More
Previous Close:
$19.59
Open:
$19.67
24h Volume:
201.69K
Relative Volume:
0.56
Market Cap:
$1.30B
Revenue:
$751.00K
Net Income/Loss:
$-74.57M
P/E Ratio:
-17.30
EPS:
-1.1031
Net Cash Flow:
$-54.46M
1W Performance:
-8.40%
1M Performance:
+0.10%
6M Performance:
+23.42%
1Y Performance:
+13.23%
1-Day Range:
$18.66
$19.67
1-Week Range:
$18.36
$21.15
52-Week Range:
$12.56
$26.30
Pulse Biosciences Inc Stock (PLSE) Company Profile
Name
Pulse Biosciences Inc
Sector
Industry
Phone
510-906-4600
Address
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
19.08 | 1.30B | 751.00K | -74.57M | -54.46M | -1.1031 |
ISRG
Intuitive Surgical Inc
|
450.06 | 159.39B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
149.43 | 41.17B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
39.52 | 33.42B | 29.14B | 1.07B | 1.52B | 1.1995 |
ALC
Alcon Inc
|
62.56 | 30.51B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
206.76 | 29.99B | 5.54B | 1.52B | 1.74B | 10.37 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Initiated | Mizuho | Outperform |
| Jul-07-25 | Initiated | Oppenheimer | Outperform |
| Jul-27-21 | Initiated | Stephens | Overweight |
| Mar-11-21 | Initiated | Maxim Group | Buy |
| Jan-26-21 | Reiterated | H.C. Wainwright | Buy |
| May-12-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-14-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-25-19 | Initiated | H.C. Wainwright | Buy |
View All
Pulse Biosciences Inc Stock (PLSE) Latest News
Is Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation? - Yahoo Finance
Pulse Biosciences (PLSE) upgraded to buy: What does it mean for the stock? - MSN
Pulse Biosciences Races Ahead on AF Trial Momentum - TipRanks
Pulse Biosciences Q1 Earnings Call Highlights - Yahoo Finance
Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference - BioSpace
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer - Quantisnow
MSN Money - MSN
Earnings call transcript: Pulse Biosciences Q1 2026 EPS beats, stock drops - Investing.com UK
(PLSE) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Earnings call transcript: Pulse Biosciences Q1 2026 EPS beats, stock drops By Investing.com - Investing.com South Africa
Q1 2026 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus
Pulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo! Finance Canada
Pulse Biosciences 1Q Loss/Shr 27c >PLSE - Moomoo
Pulse Biosciences Authorizes Insider Purchases Under Equity Program - TipRanks
Pulse Biosciences board approves affiliate participation in equity sales program - Investing.com India
Major holder in Pulse Biosciences (PLSE) eyes buys under $59.98M ATM - Stock Titan
Pulse Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Pulse Biosciences (PLSE) Q1 2025 Earnings Transcript - AOL.com
Pulse Biosciences Releases Q1 2026 Financial Results - AlphaStreet
Pulse Biosciences (PLSE) Q1 2025 Earnings Transcript - The Motley Fool
Pulse Biosciences Reports Q1 2026 Financial Results and Business Updates, Highlighting $0.4 Million Revenue from nPulse Vybrance and Clinical Progress 1535 - Minichart
Pulse Biosciences, Inc (PLSE) reports Q1 loss, lags revenue estimates - MSN
Pulse Biosciences (PLSE) Reports Strong Q1 Performance - GuruFocus
Pulse Biosciences Highlights Q1 Results, Electrophysiology Focus - TipRanks
Pulse Biosciences (NASDAQ: PLSE) Q1 loss widens as AF trials advance - Stock Titan
Pulse Biosciences Q1 2026 Earnings Call Transcript - MarketBeat
Assessing Pulse Biosciences (PLSE) Valuation After Recent Share Price Pullback And Ongoing Losses - Sahm
Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results - Investing News Network
Earnings Preview: PLSE to Report Financial Results Post-market on May 07 - Moomoo
Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Pulse Biosciences Q1 Loss Widens - marketscreener.com
Earnings Flash (PLSE) Pulse Biosciences Posts Q1 Loss $0.27 a Share, vs. FactSet Est of $0.32 Loss - marketscreener.com
Earnings Flash (PLSE) Pulse Biosciences, Inc. Reports Q1 Revenue $401,000, vs. FactSet Est of $250,000 - marketscreener.com
Earnings Flash (PLSE) Pulse Biosciences Posts Q1 Loss $0.27 a Share, Vs. FactSet Est of $0.32 Loss - Moomoo
Pulse Biosciences Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView
BRIEF-Pulse Biosciences Q1 Net Income USD -18.581 Million - TradingView
Pulse Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
PLSE Stock Price, Quote & Chart | PULSE BIOSCIENCES INC (NASDAQ:PLSE) - ChartMill
Executive pay and 71% insider stake at Pulse Biosciences (NASDAQ: PLSE) - Stock Titan
Pulse Biosciences (PLSE) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Shares Down 7.9%What's Next? - MarketBeat
Pulse Biosciences, Inc. (PLSE) Shareholder/Analyst CallSlideshow (NASDAQ:PLSE) 2026-04-27 - Seeking Alpha
Med-tech companies highlight PFA data as competition intensifies - BioWorld News
Pulse Biosciences Reports Strong nPulse Atrial Fibrillation Data - TipRanks
New nPulse atrial fibrillation data for Pulse Biosciences (NASDAQ: PLSE) - Stock Titan
Pulse Biosciences slips despite Q4 beat after deal to sell shares - MSN
Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026 - BioSpace
How (PLSE) Movements Inform Risk Allocation Models - Stock Traders Daily
Pulse Biosciences Inc Stock (PLSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.86%
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):